The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans

被引:22
|
作者
Boggs, Douglas L. [1 ,2 ]
Cortes-Briones, Jose A. [1 ,2 ]
Surti, Toral [1 ,2 ]
Luddy, Christina [1 ,2 ]
Ranganathan, Mohini [1 ,2 ]
Cahill, John D. [1 ,2 ]
Sewell, Andrew R. [1 ,2 ]
D'Souza, Deepak C. [1 ,2 ]
Skosnik, Patrick D. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA
[2] VA Connecticut Healthcare Syst, Psychiat Serv, West Haven, CT USA
关键词
Cannabis; psychomotor; tetrahydrocannabinol; CANNABINOID CB1 RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPRESSION; BASAL GANGLIA; HEART-RATE; CEREBELLUM; THC; PHARMACOLOGY; MARIJUANA; PARALLEL;
D O I
10.1177/0269881118799953
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Binding studies have demonstrated that levels of the cannabinoid receptor type-1 are highest in the basal ganglia and cerebellum, two areas critical for motor control. However, no studies have systematically examined the dose-related effects of intravenous delta-9-tetrahydrocannabinol, the primary cannabinoid receptor type-1 partial agonist in cannabis, on broad domains of psychomotor function in humans. Aims: Therefore, three domains of psychomotor function were assessed in former cannabis users (cannabis abstinent for a minimum of three months; n=23) in a three test-day, within-subject, double-blind, randomized, cross-over, and counterbalanced study during which they received intravenous delta-9-tetrahydrocannabinol (placebo, 0.015 mg/kg, and 0.03 mg/kg). Methods: Gross motor function was assessed via the Cambridge Neuropsychological Test Automated Battery Motor Screening Task, fine motor control via the Lafayette Instrument Grooved Pegboard task, and motor timing via a Paced Finger-Tapping Task. In addition, the Cambridge Neuropsychological Test Automated Battery Rapid Visual Processing Task was utilized to determine whether delta-9-tetrahydrocannabinol-induced motor deficits were confounded by disruptions in sustained attention. Results/outcomes: Delta-9-tetrahydrocannabinol resulted in robust dose-dependent deficits in fine motor control (Grooved Pegboard Task) and motor timing (Paced Finger-Tapping Task), while gross motor performance (Motor Screening Task) and sustained attention (Rapid Visual Processing Task) were unimpaired. Interestingly, despite the observed dose-dependent increases in motor impairment and blood levels of delta-9-tetrahydrocannabinol, subjects reported similar levels of intoxication in the two drug conditions. Conclusions/interpretation: These data suggest that while several domains of motor function are disrupted by delta-9-tetrahydrocannabinol, subjective feelings of intoxication are dissociable from cannabinoid-induced psychomotor effects. Results are discussed in terms of the potential neural mechanisms of delta-9-tetrahydrocannabinol in motor structures.
引用
收藏
页码:1308 / 1318
页数:11
相关论文
共 50 条
  • [1] A Systematic Review of Delta-9-Tetrahydrocannabinol (△9-THC) in Astrocytic Markers
    Ramos-Jimenez, Christian
    Petkau, Sarah
    Mizrahi, Romina
    CELLS, 2024, 13 (19)
  • [2] Impulsive behavior in rats perinatally exposed to delta-9-tetrahydrocannabinol (Δ9-THC)
    Carbajal, Monica
    Billings, Laura
    Dixon, Chelsea
    Williams, Victoria
    Sable, Helen
    NEUROTOXICOLOGY AND TERATOLOGY, 2024, 103
  • [3] The good and the bad effects of (-)-trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
    Carlini, EA
    TOXICON, 2004, 44 (04) : 461 - 467
  • [4] Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans
    Naef, M
    Russmann, S
    Petersen-Felix, S
    Brenneisen, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) : 1176 - 1184
  • [5] Detecting delta-9-tetrahydrocannabinol (Δ9-THC) and delta-8-tetrahydrocannabinol (Δ8-THC) by UV-HPL
    Tseng, Ken
    Ono, Toshi
    Hirose, Tsunehisa
    Kimata, Kazuhiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [6] Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (Δ9-THC):: No influence on neuropsychological performance
    Müller-Vahl, KR
    Prevedel, H
    Theloe, K
    Kolbe, H
    Emrich, HM
    Schneider, U
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (02) : 384 - 388
  • [7] Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Δ9-THC): No Influence on Neuropsychological Performance
    Kirsten R Müller-Vahl
    Heidrun Prevedel
    Karen Theloe
    Hans Kolbe
    Hinderk M Emrich
    Udo Schneider
    Neuropsychopharmacology, 2003, 28 : 384 - 388
  • [8] SOME BEHAVIORAL EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL DELTA-9-THC
    BAILEY, PT
    PRADHAN, SN
    GHOSH, B
    FEDERATION PROCEEDINGS, 1971, 30 (02) : A279 - &
  • [9] The effects of delta-9-tetrahydrocannabinol (THC) on inflammation: A review
    Miller, Henry P.
    Bonawitz, Steven C.
    Ostrovsky, Olga
    CELLULAR IMMUNOLOGY, 2020, 352
  • [10] Tolerance to Chronic Delta-9-Tetrahydrocannabinol (Δ9-THC) in Rhesus Macaques Infected With Simian Immunodeficiency Virus
    Winsauer, Peter J.
    Molina, Patricia E.
    Amedee, Angela M.
    Filipeanu, Catalin M.
    McGoey, Robin R.
    Troxclair, Dana A.
    Walker, Edith M.
    Birke, Leslie L.
    Stouwe, Curtis Vande
    Howard, Jessica M.
    Leonard, Stuart T.
    Moerschbaecher, Joseph M.
    Lewis, Peter B.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2011, 19 (02) : 154 - 172